Jean‐louis Montastruc
#124,394
Most Influential Person Now
Jean‐louis Montastruc's AcademicInfluence.com Rankings
Jean‐louis Montastrucmedical Degrees
Medical
#1962
World Rank
#2350
Historical Rank
Pharmacology
#194
World Rank
#234
Historical Rank
Download Badge
Medical
Jean‐louis Montastruc's Degrees
- Doctorate Pharmacology Federal University of Toulouse Midi-Pyrénées
Why Is Jean‐louis Montastruc Influential?
(Suggest an Edit or Addition)Jean‐louis Montastruc's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. (2000) (583)
- Prevalence of orthostatic hypotension in Parkinson’s disease (1997) (369)
- Effect of levodopa on pain threshold in Parkinson's disease: A clinical and positron emission tomography study (2005) (317)
- Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database. (2011) (297)
- Adverse drug reactions and off-label drug use in paediatric outpatients. (2002) (291)
- Limitations of current Parkinson's disease therapy (2003) (278)
- French health insurance databases: What interest for medical research? (2015) (263)
- Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine. (1992) (236)
- Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France. (2014) (219)
- Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease (2003) (210)
- The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients. (1997) (210)
- Abnormal ocular movements in Parkinson's disease. Evidence for involvement of dopaminergic systems. (1989) (202)
- A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up. (1994) (196)
- Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia. (1998) (160)
- A study of salivary secretion in Parkinson's disease. (1999) (158)
- Anxious and depressive symptoms in Parkinson's disease: The French cross‐sectionnal DoPaMiP study (2010) (150)
- Delayed elimination of enoxaparine in patients with chronic renal insufficiency (1991) (144)
- Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy (2007) (142)
- Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa. (1994) (142)
- The Long-Acting Dopamine Receptor Agonist Cabergoline in Early Parkinson’s Disease (2004) (139)
- Hospitalizations because of Adverse Drug Reactions in Elderly Patients Admitted through the Emergency Department (2009) (136)
- Square wave jerks in parkinsonian syndromes. (1991) (135)
- Met-enkephalin levels and opiate receptors in the spinal cord of chronic suffering rats (1980) (132)
- [Pharmacovigilance of self-medication]. (1997) (127)
- Drug‐induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France (2011) (126)
- Decreased convulsant potency of picrotoxin and pentetrazol and enhanced [3H]flunitrazepam cortical binding following stressful manipulations in rats (1980) (125)
- Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus (2010) (123)
- Cabergoline in the treatment of early parkinson's disease (1997) (122)
- Orthostatic Hypotension in Patients with Parkinson’s Disease (2001) (120)
- Early Treatment of Parkinson’s Disease with Cabergoline Delays the Onset of Motor Complications (1998) (118)
- Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease. (1996) (114)
- Sulfate and cysteine levels in the plasma of patients with Parkinson's disease. (1995) (112)
- Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods. (2006) (104)
- Transplantation for Acute Liver Failure in Patients Exposed to NSAIDs or Paracetamol (Acetaminophen) (2013) (98)
- Sleep Attacks and Antiparkinsonian Drugs: A Pilot Prospective Pharmacoepidemiologic Study (2001) (96)
- Utilisation and Safety of Low Molecular Weight Heparins (2003) (96)
- Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein. (1990) (94)
- Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study (2011) (93)
- Sleep disruption, daytime somnolence and ‘sleep attacks’ in Parkinson's disease: a clinical survey in PD patients and age‐matched healthy volunteers (2006) (90)
- L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers. (1999) (89)
- Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease (1994) (89)
- Tramadol use and the risk of hospitalization for hypoglycemia in patients with noncancer pain. (2015) (89)
- Lipolytic effects of conventional β3‐adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative β4‐adrenoceptor (1997) (89)
- Long-term treatment of Parkinson's disease with bromocriptine. (1979) (84)
- The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France (2006) (84)
- Influence of naloxone and methysergide on the analgesic effect of clomipramine in rats. (1981) (83)
- Gender differences in adverse drug reactions: analysis of spontaneous reports to a Regional Pharmacovigilance Centre in France (2002) (82)
- Pharmacological prospects for α2-adrenoceptor antagonist therapy (1992) (82)
- Prevalence and Pharmacological Factors Associated With Impulse-Control Disorder Symptoms in Patients With Parkinson Disease (2012) (82)
- Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs! (2013) (80)
- Photosensitivity to Ketoprofen (2000) (76)
- Cancer Risk of Anti-TNF-α at Recommended Doses in Adult Rheumatoid Arthritis: A Meta-Analysis with Intention to Treat and per Protocol Analyses (2012) (74)
- Pharmacological and clinical evidences on the potential for abuse and dependence of propofol: a review of the literature (2007) (73)
- Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals. (2001) (73)
- α2-Adrenoceptor Antagonists (1998) (69)
- Off-Label Prescribing in Pediatric Outpatients (2015) (69)
- Changes in short-term variability of blood pressure and heart rate during the development of obesity-associated hypertension in high-fat fed dogs. (1999) (69)
- Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog. (1994) (69)
- Assessing the Feasibility of Using an Adverse Drug Reaction Preventability Scale in Clinical Practice (2002) (67)
- Immediate‐ and delayed‐type allergic reactions to amide local anesthetics: clinical features and skin testing (2009) (67)
- Non‐steroidal anti‐inflammatory drug‐related hepatic damage in France and Spain: analysis from national spontaneous reporting systems (2006) (66)
- Delayed elimination of enoxaparin in patients with chronic renal insufficiency. (1991) (66)
- Case ascertainment and estimated incidence of drug-induced long-QT syndrome: study in Southwest France. (2008) (64)
- Parkinson's disease and weight loss: A study with anthropometric and nutritional assessment (1992) (64)
- A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by l-dopa (2002) (63)
- Pseudophaeochromocytoma in parkinsonian patient treated with fluoxetine plus selegiline (1993) (62)
- Pancreatitis associated with the use of GLP-1 analogs and DPP-4 inhibitors: a case/non-case study from the French Pharmacovigilance Database (2013) (62)
- Adverse drug reactions associated with the use of NSAIDs: a case/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002–2006 (2013) (62)
- Drug related falls: a study in the French Pharmacovigilance database (2005) (62)
- The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenergic agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanisms. (1992) (61)
- Risk of Serious Extrapyramidal Symptoms in Patients With Parkinson's Disease Receiving Antidepressant Drugs: A Pharmacoepidemiologic Study Comparing Serotonin Reuptake Inhibitors and Other Antidepressant Drugs (2003) (58)
- QT dynamicity: a prognostic factor for sudden cardiac death in chronic heart failure (2005) (56)
- Analgesic drug consumption increases after knee arthroplasty: A pharmacoepidemiological study investigating postoperative pain (2014) (56)
- Does fluoxetine aggravate Parkinson's disease? A pilot prospective study (1995) (56)
- Pharmacovigilance, risks and adverse effects of self-medication. (2016) (55)
- Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study (2003) (55)
- Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital. (2010) (54)
- Sublingual apomorphine in Parkinson's disease: a clinical and pharmacokinetic study. (1991) (54)
- [Drug-induced hiccup: a review of the France pharmacologic vigilance database]. (1999) (54)
- Serotonin Syndrome: Analysis of Cases Registered in the French Pharmacovigilance Database (2015) (54)
- Role of serotonin 5-HT2C and histamine H1 receptors in antipsychotic-induced diabetes: A pharmacoepidemiological-pharmacodynamic study in VigiBase (2015) (53)
- Perception of the risk of adverse drug reactions: differences between health professionals and non health professionals. (2002) (53)
- Factors related to orthostatic hypotension in Parkinson's disease. (2012) (53)
- Exposure to atropinic drugs and frailty status. (2015) (52)
- Searching for a polypharmacy threshold associated with frailty. (2015) (52)
- A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up. (1989) (51)
- A study of the psychometric properties of the Fagestrom Test for Nicotine Dependence. (2003) (51)
- Neuroprotection in Parkinson's Disease (1996) (49)
- Influence of naloxone on the antinociceptive effects of some antidepressant drugs. (1985) (48)
- Treatment of Parkinson's disease should begin with a dopamine agonist (2000) (47)
- New concerns about old drugs: Valvular heart disease on ergot derivative dopamine agonists as an exemplary situation of pharmacovigilance (2004) (47)
- Falsified or forged medical prescriptions as an indicator of pharmacodependence: A pilot study (1997) (47)
- Ambulatory blood pressure in patients with Parkinson's disease without and with orthostatic hypotension (1992) (46)
- What is pharmacoepidemiology? Definition, methods, interest and clinical applications. (2019) (46)
- Normal frontal perfusion in patients with frozen gait (1998) (45)
- Drugs and dilated cardiomyopathies: A case/noncase study in the French PharmacoVigilance Database. (2010) (44)
- A comparative study of the effects of yohimbine and anetholtrithione on salivary secretion in depressed patients treated with psychotropic drugs (1997) (44)
- Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital. (2006) (44)
- Drug interactions between antihypertensive drugs and non‐steroidal anti‐inflammatory agents: a descriptive study using the French Pharmacovigilance database (2014) (44)
- Levodopa monotherapy can induce “sleep attacks” in Parkinson's disease patients (2001) (44)
- Consensus statement on dementia of Alzheimer type in the severe stage. (2005) (43)
- Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A case/non-case study in a nationwide pharmacovigilance database. (2014) (43)
- Upper gastrointestinal adverse drug reactions and cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib): a case/non-case study from the French Pharmacovigilance Database (2004) (43)
- Antivertigo Medications and Drug-Induced Vertigo (1995) (42)
- Slow-release oral morphine for opioid maintenance treatment: a systematic review. (2011) (42)
- Drug-induced adverse reactions via breastfeeding: a descriptive study in the French Pharmacovigilance Database (2014) (42)
- A pilot study of N-methyl-D-aspartate (NMDA) antagonist in Parkinson's disease. (1992) (42)
- Treatment of Parkinson's disease should begin with a dopamine agonist (1999) (41)
- Death related to a recreational abuse of propofol at therapeutic dose range. (2006) (41)
- Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study (2007) (40)
- The importance of drug–drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France (2012) (40)
- Adverse Drug Reactions to Gabapentin and Pregabalin (2012) (39)
- Antivertigo medications and drug-induced vertigo. A pharmacological review. (1995) (39)
- Adverse Drug Reactions to Selegiline: A Review of the French Pharmacovigilance Database (2000) (39)
- Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients (2014) (38)
- Yohimbine increases human salivary secretion. (1989) (38)
- Sublingual apomorphine and Parkinson's disease. (1989) (38)
- Efaroxan, an alpha‐2 antagonist, in the treatment of progressive supranuclear palsy (1998) (38)
- Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study (2012) (38)
- Clinical and economic analysis of spa therapy in Parkinson's disease (2003) (38)
- [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance]. (1994) (37)
- What do pregnant women know about non‐steroidal anti‐inflammatory drugs? (2009) (37)
- Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians. (1991) (37)
- Antipsychotic use and mortality risk in community-dwelling Alzheimer's disease patients: evidence for a role of dementia severity. (2012) (37)
- Drug Prescribing Before and During Pregnancy in South West France (2011) (36)
- Is spontaneous reporting always the most important information supporting drug withdrawals for pharmacovigilance reasons in France? (2012) (36)
- Psychoactive drug consumption: performance‐enhancing behaviour and pharmacodependence in workers (2005) (36)
- Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients? (2019) (36)
- Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence (2020) (36)
- Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: a study from the French PharmacoVigilance Database (2006) (36)
- Alpha-2 adrenoceptors in lipolysis: alpha 2 antagonists and lipid-mobilizing strategies. (1992) (36)
- Glutamate antagonists and Parkinson's disease: A review of clinical data (1997) (35)
- Analysis of patients' narratives posted on social media websites on benfluorex's (Mediator®) withdrawal in France (2014) (35)
- Hepatotoxicity Related to Agomelatine and Other New Antidepressants: A Case/Noncase Approach With Information From the Portuguese, French, Spanish, and Italian Pharmacovigilance Systems (2014) (34)
- Pregnancy outcome in women exposed to dopamine agonists during pregnancy: a pharmacoepidemiology study in EFEMERIS database (2014) (34)
- Tolcapone, bromocriptine, and Parkinson's disease (1997) (34)
- Follow‐up of Adverse Drug Reactions from Peginterferon alfa‐2b—Ribavirin Therapy (2004) (34)
- Adverse drug reactions to self‐medication: a study in a pharmacovigilance database (2015) (34)
- Does memantine induce bradycardia? A study in the French PharmacoVigilance Database (2008) (33)
- Trends of reporting of 'serious'vs. 'non-serious' adverse drug reactions over time: a study in the French PharmacoVigilance Database. (2012) (33)
- Opiate maintenance with buprenorphine in ambulatory care: a 24-week follow-up study of new users. (2003) (33)
- Sufentanil is not superior to morphine for the treatment of acute traumatic pain in an emergency setting: a randomized, double-blind, out-of-hospital trial. (2010) (33)
- Drug-induced immune thrombocytopenia: A descriptive survey in the French PharmacoVigilance database (2012) (33)
- Vinorelbine‐related cardiac events: a meta‐analysis of randomized clinical trials (2004) (33)
- Pioglitazone and bladder cancer (2011) (33)
- Triptan use and risk of cardiovascular events: a nested-case-control study from the French health system database (2007) (33)
- POTENTIATION BY NALOXONE OF PRESSOR REFLEXES (1981) (33)
- Reporting rate of adverse drug reactions to the French pharmacovigilance system with three step 2 analgesic drugs: dextropropoxyphene, tramadol and codeine (in combination with paracetamol). (2009) (33)
- Perception of teratogenic and foetotoxic risk by health professionals: a survey in Midi-Pyrenees area (2008) (32)
- Neurohypophysial peptides and central cardiovascular control. (1983) (32)
- Improving Adverse Drug Reaction Reporting in Hospitals (2010) (31)
- Spinal Anesthesia Failure After Local Anesthetic Injection Into Cerebrospinal Fluid: A Multicenter Prospective Analysis of Its Incidence and Related Risk Factors in 1214 Patients (2011) (31)
- A comparative study of QT prolongation with serotonin reuptake inhibitors (2017) (31)
- Bortezomib and heart failure: case‐report and review of the French Pharmacovigilance database (2014) (31)
- Influence of HCV or HBV coinfection on adverse drug reactions to antiretroviral drugs in HIV patients (2006) (30)
- Retroperitoneal fibrosis and treatment of Parkinson's disease with high doses of bromocriptine. (1986) (30)
- Drug consumption in workers in France: a comparative study at a 10-year interval (1996 versus 1986). (1999) (30)
- An original pharmacoepidemiological–pharmacodynamic method: application to antipsychotic‐induced movement disorders (2017) (30)
- Drug-induced myoclonus: a French pharmacovigilance database study (2006) (30)
- Undesirable Effects Related to Oral Antineoplastic Drugs: Comparison Between Patients’ Internet Narratives and a National Pharmacovigilance Database (2014) (30)
- Need for an improved vaccination rate in primary immune thrombocytopenia patients exposed to rituximab or splenectomy. A nationwide population‐based study in France (2015) (30)
- Dextropropoxyphene withdrawal from a French university hospital: impact on analgesic drug consumption (2009) (30)
- Long‐term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease (2001) (29)
- Do Parkinson’s disease patients disclose their adverse events spontaneously? (2012) (29)
- Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients. (1998) (29)
- Adverse drug reactions related to drugs used in orthostatic hypotension: a prospective and systematic pharmacovigilance study in France (2005) (29)
- Is Statin Exposure Associated with Occurrence or Better Outcome in Giant Cell Arteritis? Results from a French Population-based Study (2015) (29)
- A 2-Year Prospective Cohort Study of Antidementia Drug Non-Persistency in Mild-to-Moderate Alzheimer's Disease in Europe (2014) (29)
- Drug counselling in pregnancy: an opinion survey of French community pharmacists (2004) (28)
- Adverse Drug Reactions to Anthelmintics (2004) (28)
- Statins and Erectile Dysfunction (2009) (28)
- Heat‐related morbidity in patients with orthostatic hypotension and primary autonomic failure (2005) (28)
- Drug-induced gingival overgrowth: a study in the French Pharmacovigilance Database. (2012) (27)
- Statin-induced lupus: a case/non-case study in a nationwide pharmacovigilance database (2012) (27)
- Pharmacoepidemiology and its input to pharmacovigilance. (2016) (27)
- Spontaneous reporting of serious cutaneous reactions with protein kinase inhibitors (2013) (27)
- Tramadol for noncancer pain and the risk of hyponatremia. (2015) (27)
- A comparative study of adverse drug reactions during two heat waves that occurred in France in 2003 and 2006 (2012) (27)
- Adverse Drug Reaction Reports Received Through the Mobile App, VigiBIP®: A Comparison with Classical Methods of Reporting (2018) (27)
- Potentially inappropriate medications and adverse drug reactions in the elderly: a study in a PharmacoVigilance database (2014) (27)
- A randomized, double‐blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease (1999) (27)
- Adverse drug events (2009) (27)
- [Validation of a measurement scale: example of a French Adverse Drug Reactions Preventability Scale]. (2005) (27)
- Adverse Drug Reactions to Local Anaesthetics (2009) (26)
- Use of drugs, tobacco, alcohol and illicit substances in a French student population. (2012) (26)
- Effects of acute levodopa administration on blood pressure and heart variability in never treated parkinsonians. (1995) (26)
- HMG CoA Reductase Inhibitors and Impotence (2006) (26)
- Fulminant hepatic failure after herbal medicine ingestion in children. (1998) (26)
- Immune thrombocytopenic purpura following human papillomavirus vaccination. (2009) (26)
- Identification of cellular targets involved in cardiac failure caused by PKI in oncology: an approach combining pharmacovigilance and pharmacodynamics (2017) (26)
- Pharmacological prospects for alpha 2-adrenoceptor antagonist therapy. (1992) (25)
- More on the “Triple Whammy”: antihypertensive drugs, non-steroidal anti-inflammatory agents and acute kidney injury – a case/non-case study in the French pharmacovigilance database (2014) (25)
- Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study (2016) (25)
- First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals. (2012) (25)
- EFFECTS OF LYSINE‐VASOPRESSIN AND OXYTOCIN ON CENTRAL CARDIOVASCULAR CONTROL (1982) (25)
- Effects of yohimbine on submaxillary salivation in dogs (1989) (25)
- Forged medical prescriptions in a community pharmacy network in Midi-Pyrénées area: assessment of a falsification ratio (2002) (25)
- Life‐threatening drug‐associated hyperkalemia: a retrospective study from laboratory signals (2011) (25)
- Incidence and cost of adverse drug reactions in a French cancer institute (1997) (25)
- Laboratory Monitoring of Patients Treated with Antihypertensive Drugs and Newly Exposed to Non Steroidal Anti-Inflammatory Drugs: A Cohort Study (2012) (25)
- Reversible posterior leukoencephalopathy syndrome associated with bevacizumab/doxorubicin regimen. (2008) (24)
- [Drug vigilance: opinion survey among residents of a university hospital]. (1994) (24)
- Detection and incidence of muscular adverse drug reactions: a prospective analysis from laboratory signals (2004) (24)
- Acquired factor VIII haemophilia following influenza vaccination (2010) (24)
- Differential regulation of fat cell beta-2 and beta-1 adrenoceptors by endogenous catecholamines in dog. (1989) (24)
- Scientific Evidence and Controversies About Pioglitazone and Bladder Cancer: Which Lessons Can Be Drawn? (2013) (24)
- Central interactions between dihydropyridines and cholinergic systems in the control of blood pressure in rat (1987) (24)
- Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug–drug interactions: a PharmacoVigilance study in France (2013) (24)
- Adverse drug reactions to dopamine agonists: A comparative study in the french pharmacovigilance database (2010) (24)
- Neuropathy as a potential complication of levodopa use in Parkinson's disease: A Pharmacological and Pharmacovigilance point of view (2010) (23)
- Cognition and cerebral blood flow in lateralised parkinsonism: lack of functional lateral asymmetries. (1991) (23)
- A study of tolerance to apomorphine (1996) (23)
- A Pharmacoeconomic Evaluation of Botulinum Toxin in the Treatment of Spasmodic Torticollis (2000) (23)
- Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center. (2014) (23)
- Reserpine induces vascular α2‐adrenergic supersensitivity and platelet α2‐adrenoceptor up‐regulation in dog (1990) (23)
- L5H tryptophan in the cerebellar syndrome treatment. (1981) (22)
- Lipodystrophia with protease inhibitors in HIV patients. (1997) (22)
- Changes in plasma catecholamine and neuropeptide Y levels after sympathetic activation in dogs (1992) (22)
- Prescribed drugs and violence: a case/noncase study in the French PharmacoVigilance Database (2011) (22)
- Limitations of current Parkinson's disease therapy. Discussion (2003) (22)
- Pharmacodynamics and pharmacokinetics of dermatan sulfate in humans. (1989) (22)
- Rehabilitation of patients with congestive heart failure with or without beta-blockade therapy. (2001) (22)
- Analysis of chats on French internet forums about drugs and pregnancy (2014) (22)
- High Maintenance Dosage of Clopidogrel is Associated with a Reduced Risk of Stent Thrombosis in Clopidogrel-Resistant Patients (2010) (21)
- Garlic interaction with fluindione: a case report. (2003) (21)
- Platelet alpha2 adrenoceptors in Parkinson's disease: decreased number in untreated patients and recovery after treatment (1985) (21)
- Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France (2020) (21)
- Migraine attacks induced by subcutaneous apomorphine in two migrainous parkinsonian patients. (1990) (21)
- Identification of human platelet a2‐adrenoceptors with a new antagonist [3H]‐RX821002, a 2‐methoxy derivative of idazoxan (1990) (21)
- Fluoxetine‐induced pressor response in freely moving rats: a role for vasopressin and sympathetic tone (2000) (21)
- Healthcare cost impact of biological drugs compared with traditional systemic treatments in psoriasis: a cohort analysis in the French insurance database (2014) (21)
- Predictors of Cardiovascular Hospitalization in Giant Cell Arteritis: Effect of Statin Exposure. A French Population-based Study (2016) (21)
- [Drug-induced alopecia: review of the literature]. (1995) (21)
- High Isoproterenol Doses Are Required to Activate β3-Adrenoceptor-Mediated Functions in Dogs (2003) (20)
- [Nephropathy associated with Chinese herbal drugs. 2 cases]. (1994) (20)
- Renal morphological changes after sinoaortic denervation in dogs. (1993) (20)
- Alpha 2-adrenergic sensitivity in Parkinson's disease. (1989) (20)
- Prescription of asthma medications before and during pregnancy in France: An observational drug study using the EFEMERIS database (2017) (20)
- Trends and Patterns of Antidepressant Use in French Children and Adolescents From 2009 to 2016: A Population-Based Study in the French Health Insurance Database (2018) (20)
- Drug-Induced Orthostatic Hypotension (1997) (20)
- Two weeks of treatment with deprenyl (selegiline) does not prolong l‐dopa effect in parkinsonian patients (1988) (20)
- [Adverse effects of anticancer drugs: apropos of a pharmacovigilance study at a specialized oncology institution]. (2000) (20)
- Subcutaneous apomorphine increases regional cerebral blood flow in parkinsonian patients via peripheral mechanisms. (1991) (20)
- Dopaminagonists and fibrotic valvular heart disease: Further considerations (2004) (20)
- How to take into account exposure to drugs over time in pharmacoepidemiology studies of pregnant women? (2016) (20)
- Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals (2007) (20)
- Blood Concentrations of Hydroxychloroquine and Its Desethyl Derivative Correlate Negatively with the Percentage of CD45RO+ Cells among CD4+ Lymphocytes in Hydroxychloroquine‐Treated Lupus Patients (2007) (20)
- Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database (2021) (20)
- A pilot study of stiripentol, a new anticonvulsant drug, in complex partial seizures uncontrolled by carbamazepine. (1989) (20)
- Perception of risk of adverse drug reactions by medical students: influence of a 1 year pharmacological course. (2007) (19)
- [Drug-induced parkinson syndromes]. (2004) (19)
- [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine]. (2003) (19)
- First French Experience of ADR Reporting by Patients After a Mass Immunization Campaign with Influenza A (H1N1) Pandemic Vaccines (2012) (19)
- Domperidone in the management of orthostatic hypotension. (1985) (19)
- Evolution of drug consumption in a sample of French workers since 1986: the ‘Drugs and Work’ study (2009) (19)
- Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco‐epidemiological study in VigiBase (2017) (19)
- Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco‐epidemiological study in VigiBase (2017) (19)
- Lack of yohimbine effect on ambulatory blood pressure recording: a double-blind cross-over trial in parkinsonians with orthostatic hypotension. (1993) (19)
- Are adverse drug reaction patterns different between romiplostim and eltrombopag? 2009-2013 French PharmacoVigilance assessment. (2014) (18)
- Atropinic (Anticholinergic) Burden in Parkinson's Disease (2016) (18)
- Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review (2019) (18)
- Pandemrix°, (H1N1)v influenza and reported cases of narcolepsy. (2011) (18)
- Drug consumption in a very elderly community-dwelling population (2001) (18)
- [Serious adverse drug reactions with tramadol reported to the French pharmacovigilance database between 2011 and 2015]. (2017) (18)
- A placebo-controlled study of ropinirole, a new D2 agonist, in the treatment of motor fluctuations of L-DOPA-treated parkinsonian patients. (1996) (18)
- Can drugs induce or aggravate sleep apneas? A case–noncase study in VigiBase®, the WHO pharmacovigilance database (2017) (17)
- [Taking drugs in the working environment: a study in a sample of 2106 workers in the Toulouse metropolitan area]. (2004) (17)
- Gynecomastia Associated with Fenofibrate (2007) (17)
- First epidemiological data for venotonics in pregnancy from the EFEMERIS database (2016) (17)
- Impaired activity of the supplementary motor area in akinetic patients with Parkinson's disease. Improvement by the dopamine agonist apomorphine. (1993) (17)
- Pleural adverse drugs reactions and protein kinase inhibitors: Identification of suspicious targets by disproportionality analysis from VigiBase (2018) (17)
- Was the thrombotic risk of rofecoxib predictible from the French Pharmacovigilance Database before 30 September 2004? (2008) (17)
- Psychomotor developmental effects of prenatal exposure to psychotropic drugs: a study in EFEMERIS database (2016) (17)
- [Pharmacovigilance seen by a selected group of general practitioners and of residents in the Midi-Pyrénées region]. (1995) (17)
- Interactions between Medical Residents and Drug Companies: A National Survey after the Mediator® Affair (2014) (17)
- Water drinking and the heart (1999) (17)
- Trimetazidine: A new cause for drug‐induced parkinsonism? (2005) (17)
- ["Serious" adverse drug reactions with tramadol: a 2010-2011 pharmacovigilance survey in France]. (2013) (16)
- Exposure to non-corticosteroid treatments in adult primary immune thrombocytopenia before the chronic phase in the era of thrombopoietin receptor agonists in France. A nationwide population-based study. (2015) (16)
- Role of Serotonin Transporter in Antidepressant-Induced Diabetes Mellitus: A Pharmacoepidemiological–Pharmacodynamic Study in VigiBase® (2018) (16)
- Use of administrative hospital database to identify adverse drug reactions in a Pediatric University Hospital (2014) (16)
- Cardiovascular effects of apomorphine in humans: evidence for peripheral mechanisms. (1986) (16)
- On the presence of a putative fourth β-adrenoceptor in human adipose tissue (1998) (16)
- Lacrimation in Parkinson's disease. (1994) (15)
- New Directions in the Drug Treatment of Parkinson’s Disease (1996) (15)
- Decreased high affinity state in platelet alpha 2-adrenoceptors from diabetic patients with orthostatic hypotension. (1990) (15)
- Effect of 3 weeks treatment with yohimbine on salivary secretion in healthy volunteers and in depressed patients treated with tricyclic antidepressants. (1992) (15)
- Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3‐year analysis of the multidomain Alzheimer preventive trial (MAPT) study (2018) (15)
- Risk of hormonotherapy in transgender people: Literature review and data from the French Database of Pharmacovigilance. (2016) (15)
- Pharmacological evidence of alpha 1- and alpha 2-adrenergic supersensitivity in orthostatic hypotension due to spinal cord injury: a case report. (1991) (15)
- Atropinic (anticholinergic) burden in antipsychotic‐treated patients (2018) (15)
- Drug-Induced Yawning (2007) (15)
- Pharmacovigilance and drug safety: Fair prescribing and clinical research. (2022) (15)
- Pharmacokinetic study of yohimbine and its pharmacodynamic effects on salivary secretion in patients treated with tricyclic antidepressants. (1994) (14)
- Cardiovascular effects of central injection of acetylcholine in anaesthetized dogs: a role for vasopressin release (1990) (14)
- Effects of Discontinuing Stavudine or Protease Inhibitor Therapy on Human Immunodeficiency Virus—Related Fat Redistribution Evaluated by Dual‐Energy X‐Ray Absorptiometry (2006) (14)
- Hospital re-admission associated with adverse drug reactions in patients over the age of 65 years (2016) (14)
- Alopecia: an adverse effect of bromocriptine. (1993) (14)
- Effect of intracisternal application of 6-hydroxydopamine on the antihypertensive action of propranolol in the dog. (1980) (14)
- Atorvastatin-Induced Diaphragmatic Muscle Impairment (2001) (14)
- Results of the French Pharmacovigilance in Midi-Pyrenees Region (PharmacoMIP) Network 2-Year Pilot Study (2010) (14)
- Tumor necrosis factor inhibitors added to nonbiological immunosuppressants vs. nonbiological immunosuppressants alone: a different signal of cancer risk according to the condition. A disproportionality analysis in a nationwide pharmacovigilance database (2016) (14)
- Myocardial hypertrophy, cardiac β‐adrenoceptors and adenylate cyclase activity during sinoaortic denervation in dogs (1992) (14)
- [Adverse drug reactions (ADRs) to antimalarial drugs. Analysis of spontaneous report from the French pharmacovigilance database (1996-2000)]. (2003) (14)
- Recent advances in the clinical pharmacology of Parkinson's disease. (1991) (14)
- Alpha-adrenolytic properties of bromocriptine in dogs. (1982) (14)
- Safety surveillance of influenza A(H1N1)v monovalent vaccines during the 2009–2010 mass vaccination campaign in France (2011) (14)
- Prevalence and costs of parkinsonian syndromes associated with orthostatic hypotension. (2006) (13)
- Bleeding adverse drug reactions (ADRs) in patients exposed to antiplatelet plus serotonin reuptake inhibitor drugs: analysis of the French Spontaneous Reporting Database for a controversial ADR (2012) (13)
- A comparative study of adverse drug reactions reported through hospital and private medicine. (1996) (13)
- [Bromocriptine as the 1st treatment of Parkinson's disease. Long term results]. (1982) (13)
- Exposure to inhibitors of the renin–angiotensin system is a major independent risk factor for acute renal failure induced by sucrose‐containing intravenous immunoglobulins: a case–control study (2012) (13)
- [Social pharmacology: a new topic in clinical pharmacology]. (2002) (13)
- Preventable and potentially preventable serious adverse reactions induced by oral protein kinase inhibitors through a database of adverse drug reaction reports (2015) (13)
- Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database (2011) (13)
- Interest of the trajectory method for the evaluation of outcomes after in utero drug exposure: example of anxiolytics and hypnotics (2017) (12)
- [Drug in pregnancy: studies in the French database EFEMERIS]. (2014) (12)
- Antiparkinsonian drugs (2023) (12)
- Sublingual apomorphine: a new pharmacological approach in Parkinson's disease? (1995) (12)
- Antihypertensive action of bromocriptine in neurogenic hypertensive dogs. (1981) (12)
- Anticholinergics, antimuscarinics or atropinics? About the words in pharmacology. (2010) (12)
- Treatment of acute renal colic in a French emergency department: a comparison of simulated cases and real cases in acute pain assessment and management (2001) (12)
- Acute coronary syndrome after nasal spray of oxymetazoline. (2014) (12)
- Stay vigilant: a glitazone (pioglitazone) can hide a glitazar! (2012) (12)
- Drug-Induced Anaphylaxis in a Vietnamese Pharmacovigilance Database: Trends and Specific Signals from a Disproportionality Analysis (2018) (12)
- [Liver damage and nonsteroidal anti-inflammatory drugs: case non-case study in the French Pharmacovigilance Database]. (2001) (12)
- Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One? (2019) (12)
- Insulin downregulates M2-muscarinic receptors in adult rat atrial cardiomyocytes: a link between obesity and cardiovascular complications (2005) (12)
- COVID-19 vaccines: A perspective from social pharmacology (2021) (12)
- Yohimbine increases submaxillary kallikrein release into the saliva in dogs: evidence for α2‐adrenoceptor‐mediated inhibition of cholinergic pathways (1991) (12)
- Cyberpharmacovigilance: What is the usefulness of the social networks in pharmacovigilance? (2016) (12)
- POMME: The New Cohort to Evaluate Long-Term Effects After Prenatal Medicine Exposure (2018) (11)
- Naloxone or haloperidol but not yohimbine reverse apomorphine-induced respiratory depression. (1992) (11)
- A study of dopaminergic sensitivity in Parkinson's disease: comparison in "de novo" and levodopa-treated patients. (1996) (11)
- Regional blood flows and cardiac function changes induced by angiotensin II in conscious dogs. (1988) (11)
- Odorous urine in man after asparagus. (1989) (11)
- Autonomic nervous system dysfunction and adrenoceptor regulation in Parkinson's disease. Clinical and pharmacological consequences. (1996) (11)
- Lack of autonomic nervous dysfunction in progressive supranuclear palsy, a study of blood pressure variability (2000) (11)
- Detection of drug safety signals from clinical trials data: Role of SUSARs (2018) (11)
- [Adverse drug effect notifications by nurses and comparison with cases reported by physicians]. (1995) (11)
- Ergot and non-ergot dopamine agonists and heart failure in patients with Parkinson’s disease (2016) (11)
- Parkinson's disease and hypertension (1985) (11)
- Effects of clonidine, dihydralazine and splanchnic nerve stimulation on the release of neuropeptide Y, MET-enkephalin and catecholamines from dog adrenal medulla (1993) (11)
- Overview of Pharmacovigilance System in Vietnam: Lessons Learned in a Resource-Restricted Country (2018) (11)
- Very late relapse of dapsone-induced methaemoglobinemia (2010) (11)
- Atropinic burden of prescriptions forms in patients with Alzheimer disease: a cross-sectional study in a French PharmacoVigilance Database (2015) (10)
- Infectious risk of biological drugs vs. traditional systemic treatments in moderate‐to‐severe psoriasis: a cohort analysis in the French insurance database (2018) (10)
- Pregnancy outcomes in women exposed to cancer chemotherapy (2018) (10)
- STUDY OF DRUG CONSUMPTION IN A WORKING ENVIRONMENT IN FRANCE (1988) (10)
- Atropinic burden of prescription forms in France: a study in community pharmacies in 2013 (2014) (10)
- A New Drug–Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study (2020) (10)
- What Fluoroquinolones Have the Highest Risk of Aortic Aneurysm? A Case/Non-case Study in VigiBase® (2019) (10)
- ADRENOCEPTORS IN THE DIAGNOSIS OF PHAEOCHROMOCYTOMA (1987) (10)
- Naloxone reverses the effects of enalapril and enalaprilic acid on the pressor responses to afferent vagal stimulation (1985) (10)
- Adrenoceptor regulation in orthostatic hypotension during autonomic failure. (1993) (10)
- Abnormal Movements with Donepezil in Alzheimer Disease (2000) (10)
- Psychiatric adverse drug reactions to glucocorticoids in children and adolescents: a much higher risk with elevated doses. (2008) (10)
- Hypertension and Covid-19 vaccines: are there any differences between the different vaccines? A safety signal (2021) (10)
- [Drug-induced pancreatitis. A review of French spontaneous reports]. (2015) (10)
- Antidepressants during pregnancy: a French drug utilisation study in EFEMERIS cohort (2019) (9)
- [Writing and dispensing of NSAID prescriptions in late pregnancy: impact of health authorities' advice]. (2008) (9)
- Causality of Drugs Involved in Acute Liver Failure Leading to Transplantation: Results from the Study of Acute Liver Transplant (SALT) (2013) (9)
- Risk of infections during the first year of life after in utero exposure to drugs acting on immunity: A population-based cohort study. (2016) (9)
- Risk of gastrointestinal haemorrhage with calcium antagonists. (1998) (9)
- Noradrenaline, adrenaline and tyrosine hydroxylase in adrenal medulla from parkinsonian patients. (1988) (9)
- Characterization of dog platelet alpha-adrenergic receptor: lack of in vivo down regulation by adrenergic agonist treatments. (1985) (9)
- Pharmacoepidemiology in pregnancy. (2019) (9)
- Drug information by public health and regulatory institutions: Results of an 8-country survey in Europe. (2017) (9)
- Rituximab off-label use for immune diseases: assessing adverse events in a single-centre drug-utilization survey. (2008) (9)
- A dose‐ranging study of selegiline in patients with Parkinson's disease: Effect on platelet monoamine oxidase activity (1997) (9)
- [Consumption of drugs in a population of school age subjects]. (1991) (9)
- [Drug interactions: a prospective pilot study in primary health care]. (2000) (9)
- French Pharmacovigilance Public System and COVID-19 Pandemic (2020) (9)
- [Cardiac effects of cytokines produced after rituximab infusion]. (2005) (9)
- Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase® (2020) (9)
- Risk of diabetes with fibrates and statins: a pharmacoepidemiological study in VigiBase® (2018) (8)
- Ambulatory blood pressure in patients with Parkinson's disease without and with orthostatic hypotension (2005) (8)
- NEOPHROPATHIE ASSOCIEE A DES HERBES CHINOISES : 2 CAS (1994) (8)
- β-Adrenoceptor Drugs and Parkinson’s Disease: A Nationwide Nested Case–Control Study (2020) (8)
- [Patterns of non steroidal anti-inflammatory drug use in ambulatory care]. (2006) (8)
- Utilization and costs of HIV antiretroviral drugs in Europe during the last ten years: Impact of generic antiretroviral drugs on cost reduction. (2018) (8)
- Celecoxib-Associated Torsade De Pointes (2002) (8)
- Naloxone reduces diuretic responses induced by water, alcohol or congenital lack of vasopressin in rats (1984) (8)
- Adverse drug reactions in an emergency medical dispatching centre (2014) (8)
- Drug-induced panic attacks: Analysis of cases registered in the French pharmacovigilance database. (2017) (8)
- Valvular heart disease in a patient taking 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'). (2012) (8)
- [Drug therapy of vertigo]. (1994) (8)
- Mortality and Antipsychotic Drug Use in Elderly Patients With Parkinson Disease in Nursing Homes. (2017) (8)
- Blockade of Central Calcium Channels Induces Hypertension in Dogs (1986) (8)
- INFLUENCE OF AMIODARONE ON PLASMA AND URINE DIGOXIN CONCENTRATIONS (1984) (8)
- Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database. (2019) (8)
- Parkinsonism Associated with Gabapentinoid Drugs: A Pharmacoepidemiologic Study (2019) (8)
- Tamoxifen and the risk of Parkinsonism: a case/non-case study (2018) (8)
- Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE) (2022) (8)
- Peripheral cardiovascular actions of SR 58611 A, a beta 3‐adrenoceptor agonist, in the dog: lack of central effect (1999) (8)
- Vestibulo-ocular reflex in Parkinson's disease and multiple system atrophy. (1993) (8)
- Pulmonary arterial hypertension and benfluorex: 5 case reports. (2011) (7)
- Experimental and clinical approaches to treatment of hypertension by dopamine receptor agonists. (1987) (7)
- Alpha2-adrenoceptor function in arterial hypertension associated with obesity in dogs fed a high-fat diet (2002) (7)
- [Family pharmacy: survey of a sample of patients in Midi-Pyrénées]. (2011) (7)
- Marketing versus evidence-based medicine (2012) (7)
- Fluoroquinolone-Induced Photosensitivity: A Chemical Fragment-Based Approach by a Case/Non-case Study in VigiBase® (2020) (7)
- Paradoxical adverse drug reactions: descriptive analysis of French reports (2020) (7)
- [Which analgesic after dextropropoxyphene withdrawal? A survey in a sample of general practitioners in southwest of France]. (2011) (7)
- Safety profile of enantiomers vs. racemic mixtures: it's the same? (2012) (7)
- Modifications of Low-Molecular Weight Heparin Use in a French University Hospital after Implementation of New Guidelines (2007) (7)
- Atropinic burden of drugs during pregnancy and psychological development of children: a cohort study in the EFEMERIS database. (2016) (7)
- [Functional decoupling of left ventricular beta-adrenoceptor in a canine model of obesity-hypertension]. (1998) (7)
- Blood pressure measurements after mRNA-SARS-CoV-2 tozinameran vaccination: a retrospective analysis in a university hospital in France (2022) (7)
- Antiarrhythmic drug-induced side effects: a prospective survey of 300 patients. (1995) (7)
- [Drug consumption in a retired population]. (1990) (7)
- Drug identification by the patient: Perception of patients, physicians and pharmacists. (2019) (7)
- Urinary kallikrein excretion following chronic sinoaortic denervation in conscious dogs. (1989) (7)
- Normal CSF levels of met-enkephalin-like material in a case of naloxone—Reversible congenital insensitivity to pain (1984) (7)
- Ischaemic stroke after exposure to aflibercept: interaction with vitamin K antagonist and/or direct pharmacodynamic effect? (2015) (7)
- A Prospective Intensive Study of Adverse Drug Reactions in Urban General Practice (1995) (7)
- [Preventability of adverse effects in a medical emergency service]. (2001) (7)
- CENTRAL EFFECTS OF CALCIUM ANTAGONISTS (1989) (7)
- [Prevalence of diabetes in france and drug use: study based on the French pharmacovigilance database]. (2007) (7)
- The pharmacologic treatment of gait ignition failure. (2001) (7)
- Cervical dysplasia in a patient with multiple sclerosis treated with natalizumab (2018) (7)
- [Drug-related neuropathies: analysis of the French Adverse Drug Reaction Database 1995-2005]. (2008) (7)
- Modafinil and pramipexole‐associated somnolence (2001) (7)
- [Adverse cardiovascular and central neurologic reactions to sympathomimetics used as nasal decongestants: results of the French National Pharmacovigilance Survey]. (2003) (7)
- [Prescribing drugs by international non-proprietary name: the perception of health and non-health professionals]. (2005) (7)
- Mesulergine (CU 32-085) in the treatment of Parkinson's disease. (1986) (6)
- In vivo pharmacodynamic interactions between two drugs used in orthostatic hypotension – midodrine and dihydroergotamine (2007) (6)
- A Prospective Intensive Study of Adverse Drug Reactions in Rural Medicine (1993) (6)
- Adverse Effects of Treatment with Valproic Acid during the Neonatal Period (2018) (6)
- Guidelines of the French Society of Otorhinolaryngology (SFORL): Nonsteroidal anti-inflammatory drugs (NSAIDs) and pediatric ENT infections. Short version. (2019) (6)
- Cardiovascular safety of methylphenidate should also be considered in adults (2016) (6)
- Does substitution of brand name medications by generics differ between pharmacotherapeutic classes? A population-based cohort study in France (2017) (6)
- Non‐steroidal anti‐inflammatory drug prescriptions from the 6th month of pregnancy: impact of advice from health authorities (2019) (6)
- Drugs and Sleep Apneas? A review of the French Pharmacovigilance database. (2015) (6)
- Medication errors with tramadol drops in children (2018) (6)
- [New methods for studying drug associated risk: experience of the Toulouse Regional Pharmacovigilance Center]. (2005) (6)
- [Drug-induced hyperglycemia: a study in the French pharmacovigilance database]. (2010) (6)
- Statins and diabetes: is there any difference between the different statins? (2017) (6)
- [Role of dopaminergic agonists]. (2000) (6)
- Serious adverse drug reactions with sacubitril/valsartan Entresto®: a French pharmacovigilance survey (2018) (6)
- [Midodrine (Gutron) prescription practice at a University Hospital Center]. (2000) (6)
- [Profile of psychoactive substances consumption in workplace]. (2011) (6)
- Peripheral arterial occlusive disease during ponatinib therapy after failure of imatinib: a case report (2016) (6)
- Reserpine induces vascular alpha 2-adrenergic supersensitivity and platelet alpha 2-adrenoceptor up-regulation in dog. (1990) (6)
- Comparison of adherence to generic multi‐tablet regimens vs. brand multi‐tablet and brand single‐tablet regimens likely to incorporate generic antiretroviral drugs by breaking or not fixed‐dose combinations in HIV‐infected patients (2018) (6)
- [Retrospective analysis of adverse effects of infliximab in a hospital rheumatology service]. (2003) (6)
- Adrenomedullin upregulates M2‐muscarinic receptors in cardiomyocytes from P19 cell line (2003) (6)
- Pharmacoepidemiology, the new paradigm of drug evaluation. (2019) (6)
- Use of Codeine and Non-Codeine Cough Suppressants (2002) (6)
- Naloxone fails to reverse blood pressure in shock: a double blind study in man. (1985) (6)
- Study on the Regular Use of Drugs in Workers over 50 Years of Age (1995) (6)
- Beta-adrenergic sensitivity in Parkinson's disease: effect of levodopa treatment. (1990) (6)
- [Experimental hypertension induced by hypercaloric diet]. (1996) (6)
- Drug–drug interactions with imatinib (2016) (6)
- Effects of morphine on urine flow in rats. Involvement of vasopressin. (1986) (6)
- Patterns of direct oral anticoagulant drug prescription in France in 2010–2013: a study in the Midi-Pyrénées area (2018) (6)
- [Calcium channel blockers and prevention of migraine]. (1992) (6)
- Medication errors and look‐alike tablets: the splitting issue (2016) (6)
- Severe neonatal hypercalcemia related to maternal exposure to nutritional supplement containing Spirulina (2012) (6)
- Are potentially inappropriate and anticholinergic medications being prescribed for institutionalized elderly subjects? (2020) (6)
- [Improving adverse drug reaction reporting by general practitioners through clinical research assistants visits]. (2017) (6)
- [Neuroleptic malignant-like syndrome following levodopa withdrawal]. (1990) (6)
- Gingival bleeding, a possible “serious” adverse drug reaction: An observational study in the French PharmacoVigilance Database (2017) (6)
- Role of serotonin and norepinephrine transporters in antidepressant-induced arterial hypertension: a pharmacoepidemiological-pharmacodynamic study (2020) (6)
- Effects of yohimbine and prazosin on water balance in dogs with diabetes insipidus. (1980) (6)
- Trends of atropinic (anticholinergic) exposure in the elderly: a 10‐year analysis in the French EGB database (2019) (5)
- Serious adverse drug events related to non-investigational drugs in academic clinical trials: another source of safety data for risk assessment? (2016) (5)
- A Comparative Survey of Antidepressant Drug Prescribing Habits of General Practitioners and Psychiatrists (1998) (5)
- Pharmacovigilance: The new challenges. (2016) (5)
- Influence of naloxone on the captopril-induced decrease in vagal pressor reflexes. (1984) (5)
- [Autonomic nervous system abnormalities in the initial phase of insulin resistance syndrome. Value of the study of variability of cardiac rate and blood pressure on a model of nutritional obesity]. (1997) (5)
- Reduction of vagal pressor reflexes by neurohypophyseal peptides and related compounds. (1985) (5)
- Is there any relationship between actual benefit and added value of drugs and pharmacovigilance alerts? (2009) (5)
- Chronic chlorimipramine does not reverse the reduction of cerebrospinal fluid Met-enkephalin-like immunoreactivity in chronic-pain patients. (1987) (5)
- Confusion, a rather serious adverse drug reaction with valproic acid: a review of the French Pharmacovigilance database. (2009) (5)
- Potentially inappropriate medications in the elderly in France: a study in community pharmacies in 2011–2012 (2013) (5)
- First Congress of the European Association for Clinical Pharmacology and Therapeutics. (1996) (5)
- In utero drug exposure and hearing impairment in 2-year-old children A case-control study using the EFEMERIS database. (2018) (5)
- [Adverse drug reactions in pregnant women]. (2007) (5)
- Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre. (2019) (5)
- β-adrenoceptor antagonists and nightmares: A pharmacoepidemiological-pharmacodynamic study. (2021) (5)
- [Effect of bromocriptine on cerebral blood flow in Parkinson's disease]. (1988) (5)
- [Drugs, Parkinson's disease and parkinsonian syndroms: recent advances in pharmacovigilance]. (2006) (5)
- Drug-Induced Dental Caries: A Disproportionality Analysis Using Data from VigiBase (2017) (5)
- Prise en charge thérapeutique des patients diabétiques en France : Apport de la Banque Nationale de Pharmacovigilance (2007) (5)
- EFFECTS OF CALCIUM ENTRY BLOCKERS ON BLOOD PRESSURE AND HEART RATE IN NEUROGENIC HYPERTENSIVE DOGS (1987) (5)
- Lack of haemodynamic effects of nitric oxide on post‐capillary pulmonary hypertension induced by acute sino‐aortic denervation (1997) (5)
- [Utilization of heart rate at the ventilatory threshold for the prescription of intensity of exercise training in cardiac failure]. (2000) (5)
- [Hospital readmission induced by adverse drug reaction: a pilot study in a post-emergency unit of a French university hospital]. (2015) (5)
- Interaction between lansoprazole and bromocriptine in a patient with Parkinson's disease. (2002) (5)
- [Mechanism of receptor regulation during repeated administration of drugs]. (1993) (5)
- Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports (2020) (4)
- COX-2 inhibitors and arterial hypertension: an analysis of spontaneous case reports in the Pharmacovigilance database (2005) (4)
- Campagne nationale de vaccination contre la grippe A (H1N1)v : suivi national de pharmacovigilance (2011) (4)
- Prescribe, but also know how to "deprescribe". (2013) (4)
- Naloxone does not prevent apomorphine-induced emesis or hypotension in dogs (1994) (4)
- [Atropinic burden and anticholinergic drugs: Interest and application in clinical practice in the elderly]. (2018) (4)
- [Trial of vasopressin treatment of chronic alcoholism]. (1982) (4)
- [National Campaign of Vaccination against the flu A (H1N1)v: National Follow-up of Pharmacovigilance]. (2011) (4)
- [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital]. (2008) (4)
- Hypertension with orthostatic hypotension: interest of verapamil. (1987) (4)
- Higher intake of medications for digestive disorders in children prenatally exposed to drugs with atropinic properties (2018) (4)
- Comparison of serious adverse reactions between thalidomide and lenalidomide: analysis in the French Pharmacovigilance database (2013) (4)
- [Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study]. (1990) (4)
- Weight‐loss associated with anti‐dementia drugs in a patient with Parkinson's disease (2007) (4)
- Efficacy of COVID‐19 vaccines: Several modes of expression should be presented in scientific publications (2021) (4)
- Biosimilars: from Technical to Pharmacoeconomic Considerations. (2015) (4)
- Mania associated with ranitidine: a case report and review of literature (2016) (4)
- [Post-marketing safety profile of avocado-soybean unsaponifiables]. (2010) (4)
- Weight‐loss associated with anti‐dementia drugs in a patient with Parkinson's disease (2007) (4)
- [Extrapyramidal syndrome. Possible role of metopimazine]. (1983) (4)
- [Left ventricular repercussion of obesity-induced arterial hypertension in the dog]. (1997) (4)
- Estimation of time devoted to adverse drug reactions assessment in an internal medicine department. (2005) (4)
- Effect of a 7-day treatment with idazoxan and its 2-methoxy derivative RX 821002 [correction of RX 821001] on alpha 2-adrenoceptors and non-adrenoceptor idazoxan binding sites in rabbits. (1991) (4)
- [Cardiac arrest with varenicline: a case report]. (2009) (4)
- [Study of ventricular repolarization in an experimental model of arterial hypertension associated with obesity]. (2002) (4)
- NVX‐Cov2373 Novavax Covid‐19 vaccine: A further analysis of its efficacy using multiple modes of expression (2022) (4)
- Effect of morphine on diuresis in normal and diabetes insipidus dogs. (1980) (4)
- Experimental hypertension induced by hyperlipidic and hypercaloric diet (1997) (4)
- Drug exposure and perceived adverse drug events reported by liver-transplant patients. (2009) (4)
- Apomorphine test in parkinsonian syndromes (1990) (4)
- Involvement of cholinergic mechanisms in the central cardiovascular actions of nicardipine in dogs. (1987) (4)
- The Cost of Potentially Inappropriate Medications in Nursing Homes in West Occitanie (2020) (4)
- [Drug-induced Parkinson syndrome: 10 years of drug vigilance]. (1994) (4)
- Confounding factors for variation of clozapine plasma levels: drug interactions with proton pump inhibitor or infectious etiologies? (2011) (4)
- Potentiation of the Acenocoumarol Anticoagulant Effect by Acetaminophen (1999) (4)
- [Methods for the measurement of drug consumption: application to antibiotics]. (2005) (4)
- Tolcapone, bromocriptine, and Parkinson's disease. French Tolcapone Study Group. (1997) (4)
- Clinical pharmacology of levodopa-induced dyskinesia in parkinsonian patients. (1999) (4)
- Adrenal catecholamine concentration after domperidone. (1987) (3)
- Frequency and Nature of Adverse Drug Reactions Due to Non-Prescription Drugs in Children: A Retrospective Analysis from the French Pharmacovigilance Database (2018) (3)
- Naloxone suppresses the vasodepressor action of captopril in the anaesthetized dog. (1984) (3)
- [Iatrogenic hyperkinetic syndrome caused by an antihistaminic]. (1982) (3)
- Inhaled corticosteroid-induced hair depigmentation in a child. (2013) (3)
- [Inefficacy of exchange-transfusion in case of a methotrexate poisoning]. (1997) (3)
- Flunarizine versus Pizitofen: A Double Blind Study in the Prophylaxis of Migraine (1985) (3)
- [Pharmacovigilance study of influenza A H1N1 vaccination during the 2009-2010 season in France]. (2011) (3)
- Authors’ Reply to Coste et al.: “Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?” (2019) (3)
- [Twenty-four hour time and frequency domain variability of systolic blood pressure and heart rate in an experimental model of arterial hypertension plus obesity]. (1998) (3)
- Breast cancer and spironolactone: an observational postmarketing study (2019) (3)
- [Women's knowledge of folic acid]. (2017) (3)
- [Pharmacoepidemiology: definition, methods and applications]. (2015) (3)
- [Could we improve notification of adverse drugs reactions in hospital? Assessment of 5 years of network PharmacoMIP's activities]. (2012) (3)
- The role of the adrenal medulla in the antihypertensive action of bromocriptine in neurogenic hypertensive dogs. (1983) (3)
- [Use of Nadis(®) software to improve adverse drug reaction reporting of antiretroviral drugs: experience in south west of France (midi-pyrénées)]. (2014) (3)
- Myocardial infarction and ischemic stroke with vasoconstrictors used as nasal decongestant for common cold: a French pharmacovigilance survey (2019) (3)
- Vomiting and constipation associated with tramadol and codeine: a comparative study in VigiBase® (2018) (3)
- Bleedings induced by oral anticoagulants: a study of adverse drug reactions reported to Midi-Pyrénées PharmacoVigilance Centre between 2003 and 2006. (2010) (3)
- [Consensus statement on severe dementia]. (2005) (3)
- Drugs and cancer: an analysis of the French Pharmacovigilance Database. (2013) (3)
- [Meningococcal serogroup C vaccine: a pharmacovigilance point of view]. (2005) (3)
- [Prospective survey on adverse effects of radiopharmaceuticals]. (1996) (3)
- On the presence of a putative fourth beta-adrenoceptor in human adipose tissue. (1998) (3)
- Obesity-induced hypertension in the dog: incidence on the left ventricle (1997) (3)
- Can tramadol really induce hyponatraemia? A pharmacovigilance study (2020) (3)
- Experimental studies on the anti-hypertensive effect of acebutolol in dogs: further evidence for a central site of action. (1978) (3)
- Hemorrhagic effects of oral anticoagulants: a comparative study between vitamin K antagonists (VKA) and direct oral anticoagulants (DOA) (2015) (3)
- Authors’ Reply to Castello-Bridoux et al.: “Comment on Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?” (2019) (3)
- Drug-induced osteoporosis/osteomalacia: analysis in the French and Spanish pharmacovigilance databases (2019) (3)
- Neurohypophysial peptides and central cardiovascular control in the anaesthetized dog. (1984) (3)
- [Treatment of Parkinson's disease with high doses of bromocriptine. Possible interaction with josamycin]. (1984) (3)
- Naloxone and acute neurogenic hypertension in anaesthetized dogs. (1982) (3)
- [A pilot study in general practice: pressure to prescribe]. (2003) (3)
- Adverse drug reactions with Selegiline and Rasagiline compared to Levodopa and Ropinirole: A study in the French Pharmacovigilance Database (2013) (3)
- Amiodarone and Parkinsonism: a pharmacovigilance study (2020) (3)
- Phenothiazine-induced acute colitis: a positive rechallenge case report. (1999) (3)
- Plasma dopamine-beta-hydroxylase activity in depressed patients: role of treatment. (1991) (2)
- [Movement disorders induced by drugs: experience at a pharmaco-vigilance center over five years]. (1995) (2)
- [An intensive survey of drug surveillance in a medical admissions department]. (1987) (2)
- Antihypertensive effects of intra-cisternal beta-blocking agents in dogs with acute nerogenic hypertension. (1979) (2)
- Antidepressants are not safe during pregnancy and in women of child‐bearing age (2021) (2)
- [Physiological mechanisms of cardiovascular adaptation to orthostatism. Role of the sympathetic nervous system and pharmacological implications]. (1994) (2)
- Antihypertensive drug prescription pattern before and during pregnancy in France. (2011) (2)
- Vaccination Rates in Primary Immune Thrombocytopenia Adult Patients Exposed to Rituximab or Splenectomy. a Nationwide Population-Based Study in France (2014) (2)
- Platelet alpha 2- and leucocyte beta 2-adrenoceptors in phaeochromocytoma: effect of tumour removal. (1988) (2)
- [Neurogenic arterial hypertension in humans]. (1989) (2)
- [Yohimbine in treatment of Parkinson's disease. Preliminary results (author's transl)]. (1981) (2)
- [Respiratory complications of drugs used in neurology and psychiatry]. (1986) (2)
- [Utilization of levo-5-hydroxytryptophan in post-anoxic myoclonus]. (1978) (2)
- Alpha-2 adrenoceptors in lipolysis: a2 antagonists and lipid-mobilizing 2 (1992) (2)
- Neurological and digestive bleeding with Direct Oral Anticoagulants versus Vitamin K Antagonists: The differences do not stop there! A pharmacovigilance study. (2017) (2)
- Influence of bromocriptine on the pressor responses to afferent nervous stimulation. (1984) (2)
- [Patient's medicine cabinet composition study of 207 families in France]. (2012) (2)
- [Calcium inhibiting drugs and the risk of gastrointestinal hemorrhage. A pharmaco-epidemiologic case-non-case study]. (1999) (2)
- Relationships between kallikrein secretion, kallikrein excretion and β‐adrenoceptors in kidney cortical slices from neurogenic hypertensive dogs (1995) (2)
- [Outcome of an extrapyramidal syndrome during prophylactic treatment of migraine with flunarizine]. (1988) (2)
- Arterial hypertension and resistance to antihypertensive treatment: a new adverse drug reaction with modafinil. (2013) (2)
- [Factors Associated with Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients with Non-valvular Atrial Fibrillation]. (2015) (2)
- EFFECT OF INTRACISTERNAL 5,7‐DIHYDROXYTRYPTAMINE ON THE ACUTE ANTIHYPERTENSIVE ACTION OF PROPRANOLOL IN THE SINO‐AORTIC DENERVATED ANAESTHETIZED DOG (1981) (2)
- Main determinants of weight-bearing asymmetry in hemiplegic stroke patients (2016) (2)
- [Proton pump inhibitors: Real indication or trivialized prescription?] (2016) (2)
- [Drugs contraindicated in children: a study of drug prescriptions in ambulatory medicine in the south of France (Aude Department)]. (2005) (2)
- Detection and Incidence of Drug-Induced Agranulocytosis in French and Spanish Hospital: a Prospective Analysis from Laboratory Signals (2006) (2)
- [Is there any desensitization of presynaptic alpha 2-adrenergic receptors in hypertension? Experimental and clinical studies]. (1992) (2)
- [Undesirable effects of spa treatments: apropos of a systematic, prospective spa surveillance study at Bagnères-de-Bigorre]. (1999) (2)
- [Cardio-circulatory arrest with mifepristone sulprostone combination for pregnancy interruption]. (1991) (2)
- [Movement disorders of drug origin]. (1997) (2)
- Did thirst‐blockers contribute to the exorbitant number of fatalities during the French 2003 heat wave? (2008) (2)
- [Adverse effects of contrast media: results of a 6 months study]. (2000) (2)
- [Not Available]. (2013) (2)
- Atropinic burden of prescription forms in France: a study in community pharmacies in 2013 (2014) (2)
- Clonidine inhibits diuresis caused by negative pressure breathing and left atrial distension: role of central adrenergic alpha 2 receptors. (1982) (2)
- [Extrapolation of physiopathological data to clinical practice: Example of dabigatran in off-label use]. (2014) (2)
- Effects of four calcium channel blockers on central cardiovascular control. (1989) (2)
- The role of adrenal medulla and neurohypophysis in the central and peripheral cardiovascular effects of neurohypophysial peptides. (1984) (2)
- Tramadol‐induced hypoglycemia: A pharmacovigilance study (2021) (2)
- Concomitant medications and obstructive sleep apnoea (2017) (2)
- [Neuropsychic side effects of bromocriptine in Parkinson's disease]. (1987) (2)
- Drug-Induced Hearing Loss in Children: An Analysis of Spontaneous Reports in the French PharmacoVigilance Database (2020) (2)
- [Consumption of antihypertensive agents in obese patients: a cross-sectional study in a sample of 3,291 wage-earners in the Toulous region]. (2000) (2)
- [Coxibs, which real therapeutic advance?: Recent pharmacoepidemiological data]. (2004) (2)
- Involvement of vasopressin in the cardiovascular effects of quinpirole. (1990) (2)
- [A rare cause of cyanosis: Sulphaemoglobinaemia related to thiocolchicoside (Miorel)]. (2010) (2)
- Diarrhoea with the angiotensin receptor neprilysin inhibitor sacubitril + valsartan: A pharmacovigilance study (2021) (2)
- Intestinal obstruction associated with oral midodrine (2004) (2)
- Is neuropeptide Y co-released with catecholamines in experimental arterial hypertension following sinoaortic denervation? (1992) (2)
- [Evaluation of ten years of pharmacovigilance of antihypertensive drugs in the Toulouse University Regional Hospital Center (1981-1990)]. (1993) (2)
- Levodopa up-regulates platelet α2-adrenoceptors (1990) (2)
- [Early atrial gene regulation of obesity-related arterial hypertension]. (2002) (2)
- [Acamprosate (Aotal): could adverse effects upset the treatment of alcohol dependence?]. (2003) (2)
- Perception of the Risk of Adverse Drug Reactions by Medical Students (2013) (1)
- QT prolongation and vortioxetine: a post-marketing study and comparison with other serotonin reuptake inhibitors (2020) (1)
- [Drug-induced neuropsychic disorders in a hospital environment. Retrospective study during a 6-month period]. (1983) (1)
- Effect of intracisternal butoxamine, a beta-2 adrenoceptor blocking agent, on blood pressure and heart rate in the dog. (1980) (1)
- [In Process Citation]. (2016) (1)
- [Water intraportal infusion-induced diuresis: a comparative study in normal, hypophysectomized and adrenalectomized dogs (author's transl)]. (1980) (1)
- Dopamine agonists. (2007) (1)
- [Drug prescription and pharmacovigilance in spa therapy: a comparative study at a 20-year interval (1987 versus 2007)]. (2008) (1)
- [Absence of the effect of nitric oxide on pulmonary and systemic hypertension induced by sino-aortic denervation]. (1995) (1)
- [Serotonin and migraine. Hypothesis with pathogenic and pharmacological implications]. (1991) (1)
- Authors’ Reply to Lechat et al.: “Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?” (2019) (1)
- Comment on: “Drug-Induced Hyperglycaemia and Diabetes” (2016) (1)
- [Inter-regional differences in dysthyroidism due to amiodarone: comparison of spontaneous notifications in Aquitaine, Midi-Pyrenees and Languedoc-Roussillon]. (2001) (1)
- Blood Transaminase Elevation with Pegylated Interferon Alfa 2b Plus Ribavirin in an HIV/HCV Coinfected Haemophilic Patient (2006) (1)
- Extrapyramidal effects of antipsychotics: a Pharmacodynamic-pharmacoepidemiological study in Vigibase®: Co-046 (2016) (1)
- [Amiodarone-induced pleuropneumopathies: experience 1983-1993 in a drug vigilance Regional Center]. (1994) (1)
- [Bromocriptine versus levodopa in the early treatment of Parkinson's disease. 1st results after 2 years]. (1988) (1)
- Risk comparison of beta‐lactam‐induced anaphylaxis: Therapeutic stratification analysis in a Vietnamese pharmacovigilance database (2021) (1)
- Interest of a general practitioner pharmacovigilance network to provide drug information: A comparative study in France. (2020) (1)
- Yohimbine increases salivary secretion in depressed patients treated with tricyclic antidepressants (2004) (1)
- [Drug consumption in sports and school medicine]. (1991) (1)
- 921 CONTRIBUTION OF DRUG-INDUCED LIVER INJURY (DILI) IN LIVER TRANSPLANTATION (OLT) INDICATION FOR ACUTE LIVER FAILURE (ALF) IN ADULTS IN FRANCE (2011) (1)
- [Reduction of the pressor effect of fluoxetine after V1A-vasopressin receptor blockade in the conscious rats]. (1999) (1)
- [Ambulatory measurement of blood pressure and plasma catecholamines in the study of orthostatic hypotension]. (1994) (1)
- Drug Perception by Children: A Survey of 138 Children at School in South-West France (2007) (1)
- [Role of alpha 1 adrenergic receptors in water balance in the rat]. (1983) (1)
- Fluoroquinolones and aortic aneurysms: Which fluoroquinolones are at risk? (2019) (1)
- Tesofensine and weight loss (2009) (1)
- Reply to the commentary by Onuigbo on the article “Exposure to inhibitors of the renin–angiotensin system is a major independent risk factor for acute renal failure induced by sucrose‐containing intravenous immunoglobulins. A case–control study” (2012) (1)
- Effect of tropatepine, an anticholinergic drug, on regional cerebral blood flow in patients with Parkinson's disease. (1989) (1)
- [Analysis of antiretroviral drugs-induced adverse effects]. (2006) (1)
- Effects of adrenolytic drugs on the antihypertensive action of beta-blocking agents in the acute neurogenic hypertensive dog. (1981) (1)
- [Levodopa+selegiline combination and increase of risk of mortality in the treatment of Parkinson disease]. (1996) (1)
- [Pharmacological basis for the therapeutic use of ergot alkaloids]. (1983) (1)
- [For an optimal use of fixed drug combinations]. (2017) (1)
- Levodopa up-regulates platelet alpha 2-adrenoceptors. (1990) (1)
- Adverse Drug Reactions Involving Protein Kinase Inhibitors: A French Pharmacovigilance Database Study Comparing Safety in Younger and Older Patients (≥ 75 years) with Cancer (2018) (1)
- NSAID Exposure and Risk of Acute Liver Failure Leading to Transplantation: Preliminary Results of the Study of Acute Liver Transplant (SALT) in 7 European Countries (2011) (1)
- [Pharmacologic approach to autonomic failure]. (1998) (1)
- [How do we explain the antihypertensive effect of bromocriptine? Clinical and experimental contribution]. (1984) (1)
- Adverse Drug Reactions, Iatrogenic Diseases, Drug Safety, and Pharmacovigilance: Importance and Interest for Patients and Their Physicians (2021) (1)
- Tintin in the Land of Drugs: A pharmacological, pharmacovigilance approach. (2019) (1)
- [Role of adverse effects of immuno-allergic nature at a Regional Pharmacovigilance Center]. (1992) (1)
- Hyponatraemia in a Patient Treated with Bromocriptine (1993) (1)
- PP14. Cost of serious adverse drug reactions related to anti-cancer chemotherapy (1997) (1)
- Locally activated coagulation induced by a peripheral endovenous catheter. (1991) (1)
- Effects of captopril on blood pressure in neurogenic hypertensive dogs. (1983) (1)
- [Pharmacologic criteria for medical substitution in opiate dependence]. (2003) (1)
- ANTIHYPERTENSIVE EFFECTS OF MESULERGINE: FURTHER EVIDENCE FOR A PERIPHERAL SITE OF ACTION OF DOPAMINE AGONISTS (1987) (1)
- [Myasthenia induced by tiopronin in the treatment of rheumatoid arthritis]. (1995) (1)
- Drug-induced hypohidrosis and anhidrosis: analysis of the WHO pharmacovigilance database 2000–2020 (2022) (1)
- Are lipid‐lowering drugs associated with a risk of cataract? A pharmacovigilance study (2019) (1)
- In vivo effects of fenoldopam on autonomic nervous system after inhibition or activation of ganglionic transmission. (2002) (1)
- [Clinical pharmacology and bases of the treatment of orthostatic hypotension]. (1987) (1)
- [In Process Citation]. (2016) (1)
- [Apropos of a prospective systematic survey of pharmacovigilance in chemist's shops]. (1996) (1)
- Coxibs: evolution of prescription's behaviour in France (2007) (1)
- [Central cardiovascular effect of isoprenaline and some adrenergic beta blocking agents in neurogenic hypertensive dog: role of central beta-adrenoceptors (author's transl)]. (1978) (1)
- The Role of Adrenal Medulla in the Antihypertensive Effects of Drugs (1985) (1)
- Authors’ Reply to Krebs-Brown et al. Comment on: “Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?” (2019) (1)
- Comparative effect of isoprenaline, dopamine and angiotensin on drinking, diuresis and natriuresis in normal and diabetic insipidus dogs. (1979) (1)
- Influence of the reiterated ingestion of an aluminum gel on plasma and urine levels in the normal subject (1988) (1)
- [Analysis of prescriptions associated to hormone replacement therapy in Midi-Pyrénées region]. (2012) (1)
- Aromatase inhibitors and the incidence of Parkinson disease: A population‐based cohort study (2022) (1)
- [Neurohumoral factors and the vasomotor system]. (1986) (1)
- Changes in beta‐adrenergic receptivity during human left ventricular hypertrophy due to pressure overload (1993) (1)
- Traitement de la maladie de Parkinson par doses élevées de bromocriptine: interaction possible avec la josamycine (1984) (1)
- [Drug prescription and drug monitoring in crenotherapy]. (1990) (1)
- Diarrhea and angiotensin II receptor blockers: Is there any difference between the different drugs? (2021) (1)
- Acute pseudo-aldosteronism syndrome induced by liquorice. (2003) (1)
- Addendum to: Online Reporting of Adverse Drug Reactions: A Study from a French Regional Pharmacovigilance Center - Thérapie 69 (5): 395-400 (2014) DOI: 10.2515/therapie/2014035. (2015) (1)
- 2.280 RELATIONSHIP BETWEEN POLYPHARMACY AND FREQUENCY OF ADVERSE EVENTS TO ANTIPARKINSONIAN DRUGS: A PRELIMINARY STUDY (2012) (1)
- [Extrapyramidal syndromes caused by flunarizine. Apropos of 6 cases]. (1990) (1)
- [Could you give me this drug without prescription?]. (1995) (1)
- Study of platelet alpha 2-adrenoceptors in Parkinson's disease. (1987) (1)
- Splenic Infarction in a Narcoleptic Patient Treated With Methylphenidate, Venlafaxine, and Pitolisant (2020) (1)
- Hospital re-admission associated with adverse drug reactions in patients over the age of 65 years (2016) (0)
- Gastrointestinal haemorrhage and calcium antagonists: a case/non-case study (1999) (0)
- Potentially inappropriate medications and adverse drug reactions in the elderly: a study in a PharmacoVigilance database (2014) (0)
- [Pharmacological vigilance and pharmacological epidemiology: principles, definition, methods and current trends in neurology]. (1999) (0)
- Influence of methyldopa and bromocriptine on negative pressure breathing-induced diuresis. (1984) (0)
- Use of administrative hospital database to identify adverse drug reactions in a Pediatric University Hospital (2014) (0)
- [Changes in myocardial beta adrenergic receptors in left ventricular hypertrophy caused by barometric and volumetric overloads]. (1994) (0)
- A study oftolerance toapomorphine (1996) (0)
- infections during the first year of life after in utero exposure to drugs acting on immunity: follow-up of children from the Efemeris database : co-024 (2014) (0)
- [Not Available]. (2006) (0)
- Plasma catecholamines and platelet alpha2-adrenoceptors in human and experimental orthostatic hypotension (1990) (0)
- [Consumption of drugs by a blood donor population]. (1990) (0)
- Reply to: Comment on “Parkinsonism Associated with Gabapentinoid Drugs: A Pharmacoepidemiological Study” (2020) (0)
- [Value of the study of circulating adrenergic receptors in the diagnosis and surveillance after surgery of pheochromocytoma]. (1988) (0)
- Author’s Reply to Trechot: “Comment on Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?” (2019) (0)
- Duloxetine and gingival bleeding: a case-report and reviews of the French and World PharmacoVigilance Databases and literature (2017) (0)
- Adverse drug reactions in an emergency medical dispatching centre (2014) (0)
- [Antiparkinsonian drug consumption in a University Hospital Center 1981-1990]. (1992) (0)
- Central Adverse Drug Reactions (ADRs) Induced by Non Neuropsychotropic Drugs: A Survey on French PharmacoVigilance Database (2007) (0)
- Impact of the etiology of congestive heart failure on chronotropic reserve after exercise training (2000) (0)
- Erratum to Current status of dopamine agonists in Parkinson’s disease (1996) (0)
- 36 Cosecretion of neuropeptides and catecholamines by the adrenal medulla (1993) (0)
- Severe intracranial bleeding related to vitamin K Antagonist‐Ropinirole interaction (2011) (0)
- Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug–drug interactions: a PharmacoVigilance study in France (2012) (0)
- [Ambulatory monitoring of blood pressure in orthostatic hypotension of Parkinson disease]. (1993) (0)
- [Apropos of recent antidepressant drugs: some pharmacological comments]. (1997) (0)
- [From pharmacovigilance to pharmacoepidemiology and risk coordination]. (2009) (0)
- [Potential drug-drug interactions in general practice: comparison of two transversal studies in 1997 and 2012]. (2013) (0)
- [Iatrogenic agranulocytosis. Etiology, diagnosis, treatment]. (1996) (0)
- Authors’ Reply to Yu et al.: “Levothyrox® New and Old Formulations: Are They Switchable for Millions of Patients?” (2019) (0)
- [Muscular pain and hypolipidaemic drugs: a cross-sectional study in cardiological outpatient practice]. (2005) (0)
- Parenteral Anticoagulants Use in General Practice (2015) (0)
- Is pharmacodependence a response to stress (1995) (0)
- Tramadol and the risk of bleeding complications in patients on oral anticoagulants: a pharmacovigilance study (2023) (0)
- Adverse drug reactions (ADRs) of tumour necrosis factor inhibitors (Adalimumab, Infliximab, Etanercept) in a paediatric population: a study in the French pharmacovigilance database (2016) (0)
- Exposure to montelukast during the first trimester of pregnancy: first French data: Co-022 (2016) (0)
- 13 Beta-adrenergic receptivity in human left ventricular hypertrophy due to pressure overload (1993) (0)
- Hypertension II clinical aspects and therapeutics (2004) (0)
- Lipid-lowering drugs and the risk of cataract: An Observational Post Marketing Study (2020) (0)
- [Generalized angioedema with capillary leak syndrome after piroxicam use: a case]. (2003) (0)
- Statins and diabetes: Are all statins at risk? A pharmacoepidemiological study (2018) (0)
- Effect of intravenous or intracisternal clonidine and propranolol on plasma renin. Activity in hypertensive dogs. (1979) (0)
- Evidence for a presynaptic ??2-adrenoceptor desensitization in arterial hypertension. Experimental and clinical studies (1992) (0)
- [Myoclonias secondary to gabapentin in a patient with chronic renal failure]. (2011) (0)
- Rhabdomyolysis and statins: a pharmacovigilance comparative study between statins (2023) (0)
- Effect of nicardipine and BAY K-8644 on the pressor responses to afferent nervous stimulation in dogs. (1989) (0)
- Adverse drug reactions and ivermectin in COVID-19 (2022) (0)
- Ergot and non-ergot dopamine agonists and heart failure in patients with Parkinson’s disease (2016) (0)
- 14 Changes in beta‐adrenergic receptors during left ventricular hypertrophy caused by chronic pressure or volume overload (1994) (0)
- Infectious risk of biological drugs versus conventional systemic treatments in moderate to severe psoriasis (2015) (0)
- An explosive reaction to a spider-bite (2014) (0)
- HMG CoA Reductase Inhibitors and impotence: Results of a Case/Noncase study in the French PharmacoVigilance Database (2013) (0)
- [In Process Citation]. (2016) (0)
- Tamoxifen administration and the risk of Parkinsonism (2018) (0)
- Duloxetine and gingival bleeding: a case-report and reviews of the French and World PharmacoVigilance Databases and literature (2017) (0)
- [What illegal substances are used by sportsmen? a study in Midi-Pyrénées Doping Preventing Medical Centre (AMPD-MP)]. (2010) (0)
- Comparison of Adverse Reactions Notified with Three Step 2 Analgesic Associations in France: Dextropropoxyphen + Acetaminophen, Tramadol + Acetaminophen, Codeine + Acetaminophen (2008) (0)
- [Adverse drug reactions reporting is helping "non substituable" prescription!]. (2014) (0)
- Transcelldar biosynthesis of leukotrienes and lipoxins via ~e~ot~ene & transfer (1993) (0)
- Adverse Drug Reactions and Off-Label Drug Use in Paediatric Patients: A One-Year Survey of the French Pharmacovigilance Database (2008) (0)
- [Role of the adrenal medulla in the effect of antihypertensive drugs]. (1985) (0)
- [Reevaluation of causality assessment of adverse drug reactions reported in internal medicine]. (2005) (0)
- [Development of antibiotic consumption at the Regional University Hospital Center of Toulouse from 1980 to 1989]. (1992) (0)
- QT prolongation and vortioxetine: a post-marketing study and comparison with other serotonin reuptake inhibitors (2020) (0)
- [Effect of clonidine on three types of experimental hypertension and on plasma renin activity in dogs]. (1978) (0)
- Serious adverse drug reactions with sacubitril/valsartan Entresto®: a French pharmacovigilance survey (2018) (0)
- Myocardial infarction and ischemic stroke with vasoconstrictors used as nasal decongestant for common cold: a French pharmacovigilance survey (2019) (0)
- [Prevention of adverse effects of drugs]. (2001) (0)
- Yohimbine and lacrimal secretion. (1990) (0)
- Bleeding adverse drug reactions (ADRs) in patients exposed to antiplatelet plus serotonin reuptake inhibitor drugs: analysis of the French Spontaneous Reporting Database for a controversial ADR (2012) (0)
- [Effect of propranolol on basal oxygen consumption. Study in humans in respiratory arrest under general anesthesia or in a deep coma]. (1981) (0)
- Stay vigilant: a glitazone (pioglitazone) can hide a glitazar! (2012) (0)
- Do Parkinson’s disease patients disclose their adverse events spontaneously? (2011) (0)
- [Tribute to professor Pierre Duchene-Marullaz (1921-2014)]. (2014) (0)
- [Drug-induced esophageal ulcer. Apropos of a new case]. (1993) (0)
- [Pharmacoepidemiological study of methadone in a center of addiction management: adverse effects and combined drug consumption]. (1996) (0)
- A major rethink is needed on reporting adverse drug reactions (2012) (0)
- Pharmacologic web-based practice exam for 1st year medical school: relationship between marks obtained at practice test and final competitive examination (2014) (0)
- 2.279 Adverse Events to Antiparkinsonian Medications in Parkinsonian and Non-Parkinsonian Patients (2012) (0)
- [Prenatal exposure to psychoactive substances: results of NENUPHAR study]. (2007) (0)
- Vomiting and constipation associated with tramadol and codeine: a comparative study in VigiBase® (2018) (0)
- Drugs and Dupuytren’s disease: a pharmacovigilance study in VigiBase® (2021) (0)
- EFEMERIS: A French Database Allowing Evaluation of Risks Related to Drugs in Pregnancy (2007) (0)
- Drug-Induced Dental Caries, Lessons from a Disproportionality Analysis in Vigibase®: Beware of Bisphosphonates, Atropinic, Immunosuppressant and Hyperglycaemic Drugs (2017) (0)
- Signal for a Different Risk of Thrombosis Between Eltrombopag and Romiplostim (2014) (0)
- Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study (2012) (0)
- [Platelet alpha 2 adrenergic receptors, plasma catecholamines and orthostatic hypotension in insulin-dependent diabetic patients]. (1990) (0)
- A comparative study of QT prolongation with serotonin reuptake inhibitors (2017) (0)
- Correction to: Drug-Induced Dental Caries: A Disproportionality Analysis Using Data from VigiBase (2018) (0)
- Tamoxifen administration and the risk of Parkinsonism (2018) (0)
- [Not Available]. (2015) (0)
- [Consensus statement on severe dementia]. (2005) (0)
- [In Process Citation]. (2016) (0)
- Junior doctors' attitudes towards drug companies. (2013) (0)
- ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006 (2006) (0)
- ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006 (2006) (0)
- [Economic impact of generic substitution in the southwest of France: study of prescription and delivery of generic drugs based on Caisse Primaire d'Assurance Maladie de la Haute-Garonne data ]. (2003) (0)
- 34 Neuropeptide Y, sympathetic nervous system, arterial hypertension and (1991) (0)
- Dopamine and Hypertension (2019) (0)
- Closing session. Which role for regional PharmacoVigilance centers (RPVC) in the new European PharmacoVigilance regulation (2012) (0)
- Cardiovascular effects ofcentral injection ofacetylcholine in anaesthetized dogs: arole forvasopressin release (1990) (0)
- [Principle of the proper use of drugs and non-drug therapies]. (2018) (0)
- Paradoxical adverse drug reactions: descriptive analysis of French reports (2020) (0)
- [Vascular ergotism. Acute ischemia of the lower limb during oral treatment with methylergometrin]. (1987) (0)
- [Influence of blood pH on pressor effec of dopamine]. (1977) (0)
- Thiocolchicoside during pregnancy: first clinical data in Efemeris: Co-019 (2016) (0)
- Patterns of direct oral anticoagulant drug prescription in France in 2010–2013: a study in the Midi-Pyrénées area (2018) (0)
- Immediate-and delayed-type allergic reactions to amide local anesthetics : clinical features and skin testing y (2011) (0)
- [Bleeding risk and acute coronary syndromes in the elderly]. (2011) (0)
- Antidepressants are not safe during pregnancy and in women of child bearing age. (2021) (0)
- [Statins: details]. (2014) (0)
- Potentially inappropriate medications in the elderly in France: a study in community pharmacies in 2011–2012 (2012) (0)
- Poster Presentations (2007) (0)
- [Effects of clonidine on diuresis and water intake in normal and Brattleboro rats. (author's transl)]. (1981) (0)
- [Peripheral autonomic (nonrespiratory) effects of the stimulation of posterior cerebral fossa structures: neurophysiological and neuropharmacological aspects]. (1985) (0)
- Authors’ Reply to Nicolas: “Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?” (2019) (0)
- [Adverse effects of locally applied drugs]. (2000) (0)
- Effect of oxodipine, a novel dihydropyridine calcium channel blocker, in neurogenic hypertensive dogs. (1993) (0)
- [Fatal adverse effects. Experience of the Midi-Pyrénées Pharmacovigilance Center]. (1993) (0)
- Drug-induced adverse reactions via breastfeeding: a descriptive study in the French Pharmacovigilance Database (2014) (0)
- Cardiovascular risks and nonsteroidal anti-inflammatory drugs in the elderly recommendations for prescription. (2015) (0)
- P73 Preliminary results of the Study of Acute Liver Transplant (SALT): NSAID exposure and risk of acute liver failure leading to transplantation in 7 European countries (2011) (0)
- [Dobesilate-induced serious neutropenia]. (2009) (0)
- Myocardial ??-adrenoceptors and left ventricular hypertrophy due to pressure overload in humans (1992) (0)
- [Demonstration of a central hypotensive action of lysine vasopressin in the dog]. (1981) (0)
- [Changes in water metabolism in rats under the influence of naloxone: role of vasopressin]. (1985) (0)
- [Apropos of secondary effects of hydroxyzine]. (1994) (0)
- #11 Adverse drug reactions on female fertility: A study in VigiBase® (2019) (0)
- Failing of left ventricular β adrenergic affinity in a canine model of obesity-hypertension (1998) (0)
- More about the safety of propofol (2017) (0)
- Detection of drug-induced hydro-electrolytic adverse reactions by retrospective analysis of renal and metabolic physiological investigations data: Ps-011 (2016) (0)
- Safety of pitolisant: a study in the WHO international pharmacovigilance database (2023) (0)
- [Arterial hypertension with orthostatic hypotension caused by dysregulation of the baroreflex. Correction with domperidone and verapamil]. (1986) (0)
- Patient reporting of adverse drug reactions: first french experience after mass immunization campaign with (H1N1)v pandemic vaccines (2011) (0)
- [Beta-adrenergic receptivity and left ventricular hypertrophy caused by pressure overload in man]. (1993) (0)
- Myocardial beta-adrenoceptors in experimental hypertension (1991) (0)
- Generic antiretroviral use in Hiv-infected patients: a cohort study from the French national healthcare insurance database in midi-pyrénées region: Ps-034 (2016) (0)
- [Pharmacoepidemiology in clinical practice]. (2002) (0)
- Effects of Dopaminergic on the Sympathoadrenal Drugs System (2006) (0)
- Medication errors with tramadol drops in children (2017) (0)
- Risk of diabetes associated with statins and fibrates and their association: A disproportionality analysis using the WHO spontaneous reporting database, Vigibase® (2019) (0)
- Medullary opiate peptides in a case of congenital insensitivity to pain (1985) (0)
- [Endomorphins and experimental analgesic action of amitriptyline]. (1983) (0)
- [Generic substitution in primary care in 2011: differences according to pharmacological classes?]. (2013) (0)
- Effects of apomorphine on cerebral blood flow and extrapyramidal symptoms in Parkinson's disease (1990) (0)
- Poster Presentations (2007) (0)
- Does substitution of brand name medications by generics differ between pharmacotherapeutic classes? A population-based cohort study in France (2016) (0)
- Relationship Between Myocardial Beta‐Adrenergic Sensitivity and Heart Rate Variability (2000) (0)
- [Parkinsonian syndrome. Etiology, diagnosis, treatment]. (1990) (0)
- The importance of drug–drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France (2011) (0)
- Myocardial hypertrophy in experimental hypertension (1991) (0)
- Hospital admission due to bleeding in patients with atrial fibrillation: antiplatelet agents or oral anticoagulants?: Ps-030 (2016) (0)
- [Beta adrenergic receptors and experimental left ventricular hypertrophy]. (1992) (0)
- Adverse Drug Reactions Involving Protein Kinase Inhibitors: A French Pharmacovigilance Database Study Comparing Safety in Younger and Older Patients (≥ 75 years) with Cancer (2018) (0)
- V1A-vasopressin receptor blockade reduces the fluoxetine-induced pressor response in freely moving rats (1999) (0)
- Fatal adverse drug reactions in children: A descriptive study in the World Health Organization pharmacovigilance database, 2010–2019 (2022) (0)
- [Hypotensive action of a dopaminergic agonist, bromocriptine, in the dog]. (1981) (0)
- Spontaneous reporting of serious cutaneous reactions with protein kinase inhibitors (2013) (0)
- WATER DRINKING AND THE HEART. AUTHORS' REPLY (1999) (0)
- POMME cohort: Analysis of drug exposure in children from the first day of the intrauterine life until 6 years old (2018) (0)
- [Development of antihypertensive drug consumption in the Toulouse University Regional Hospital Center from 1981 to 1989]. (1991) (0)
- Asthma medication during pregnancy: A cohort study in EFEMERIS database (2015) (0)
- [Are newspapers a reliable source of information about doping in sports?]. (2004) (0)
- Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs! (2013) (0)
- 2.284 Impulse-Control Disorders in Parkinson's Disease Patients (2012) (0)
- Severe neonatal hypercalcemia related to maternal exposure to nutritional supplement containing Spirulina (2011) (0)
- Differential regulation of noradrenaline and neuropeptide Y release (1992) (0)
- [Effects of propranolol in experimental arterial hypertension]. (1977) (0)
- Pharmacoepidemiology for everybody (2001) (0)
- NSAID Exposure and Risk of Acute Liver Failure Leading to Transplantation: Principal Results of the 7-Country Case-Population Study (SALT) (2011) (0)
- Therapies celebrated its 75th anniversary! (2021) (0)
- [Cerebral hemodynamics and clinical pharmacology in Parkinson disease]. (1988) (0)
- Atropinic burden of prescriptions forms in patients with Alzheimer disease: a cross-sectional study in a French PharmacoVigilance Database (2015) (0)
- Exposure to Corticoid-Sparing Treatments in Adult Primary Immune Thrombocytopenia before the Chronic Phase in the Era of Thrombopoietin Receptor Agonists in France. a Nationwide Population-Based Study (2014) (0)
- In utero drug exposure and hearing disorders in 2-year-old children: A case-control study using the EFEMERIS database (2018) (0)
- [Not Available]. (2014) (0)
- [Morphine antagonists]. (1983) (0)
- Tamoxifen and the risk of Parkinsonism: a case/non-case study (2018) (0)
- [Myocardial beta-adrenergic receptors and left ventricular hypertrophy induced by pressure overload in man]. (1992) (0)
- [Bromocriptine and pleuropulmonary fibrosis]. (1986) (0)
- Comparison of safety profile of racemate drugs and their enantiomers: analysis of the french pharmacovigilance database (2011) (0)
- P2-392: Predictive factors of discontinuation and switch of cholinesterase inhibitors in Alzheimer's disease (2008) (0)
- Differences in the location of bleeding with Direct Oral Anticoagulants versus Vitamin K Antagonists: A study in the World Health Organization's pharmacovigilance database. (2023) (0)
- [Lithium and the converting enzyme inhibitor: a dangerous combination]. (1988) (0)
- Which pharmacovigilance for vaccines? (2016) (0)
- Evidence for the involvement of central alpha 2 mechanisms in intrathoracic volume expansion--induced diuresis: a study with clonidine and propranolol. (1982) (0)
- TNF inhibitor exposure and cancer? Data of case/non case study in French PharmacoVigilance Database (2013) (0)
- [On the potentiation of the effects of phenobarbital by dipropylacetic acid (author's transl)]. (1980) (0)
- [Severe myopathy related to colchicine poisoning: a case report]. (2012) (0)
- [Finger agenesis after in utero exposure to ketoconazole: a case report]. (2003) (0)
- ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006 (2006) (0)
- Urinary kallikrein excretion in neurogenic hypertension in the dogs: possible relationship between kallikrein excretion and catecholamines. (1989) (0)
- Drug-Induced Movement Disorders in Elderly Patients (2014) (0)
- Does papaverine interact with levodopa in Parkinson's disease? (1987) (0)
- [Can blockade of presynaptic adrenergic beta receptors explain the antihypertensive effects of propranolol?]. (1979) (0)
- [Drugs and heat wave: SIRIUS, a multicentric case-control study in patients older than 65 years during 2007 summer in France]. (2009) (0)
- [Evaluation of the pharmacovigilance follow-up of zidovudine]. (1990) (0)
- [Influence of nephrectomy on the antihypertensive effects of propranolol in the dog (author's transl)]. (1981) (0)
- Adverse gastrointestinal outcomes and cyclo-oxygenase-2 inhibitors (2017) (0)
- Authors’ Reply to Nicolas: “Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?” (2019) (0)
- [Drug-induced tremor and acute movement disorders]. (2004) (0)
- 1921-2021, from insulin to new hypoglycaemic drugs: 100 years of pharmacological research in diabetes mellitus. (2021) (0)
- Blockade by clonidine of negative pressure breathing-induced diuresis in the dog. (1981) (0)
This paper list is powered by the following services:
